Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
64 participants
INTERVENTIONAL
2020-09-16
2025-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Omega-3 Status and Supplementation on Tendon Structure in Competitive Athletes
NCT03880149
Collagen Peptide Supplementation and Lifelong Athletes
NCT05751005
Resistance Training and Hydrolyzed Collagen Supplementation in Middle-aged Adults
NCT06402890
Muscle-Tendon Mechanics During Locomotor Tasks, Efficacy of Collagen Supplementation for Older Adults
NCT03563261
Resistance Training and Hydrolyzed Collagen Supplementation in Healthy Young Adults
NCT06372080
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Collagen + heavy slow resistance group
Daily collagen supplementation + heavy slow resistance training three times weekly for 12 weeks.
Hydrolyzed collagen
Hydrolyzed collagen supplementation twice daily
Heavy slow resistance training
Heavy slow resistance training 3 times weekly
Placebo + heavy slow resistance group
Daily placebo supplementation + heavy slow resistance training three times weekly for 12 weeks.
Heavy slow resistance training
Heavy slow resistance training 3 times weekly
Placebo
Placebo supplementation twice daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hydrolyzed collagen
Hydrolyzed collagen supplementation twice daily
Heavy slow resistance training
Heavy slow resistance training 3 times weekly
Placebo
Placebo supplementation twice daily
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18-40 years old
* Exercise related tendon pain on one or both legs
* Soreness during physical examination of tendon upon palpation
* Uni- or bilateral tendinopathy symptoms \> 3 months
Exclusion Criteria
* Diabetes
* Arthritis
* Corticosteroid injection for tendinopathy within the last 3 months
* Any form of tendon injection within the last 3 months
* Smoking
18 Years
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Team Denmark
OTHER
University of Aarhus
OTHER
Bispebjerg Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christian Couppé
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christian Couppé, PhD
Role: STUDY_DIRECTOR
Institute of Sports Medicine
Louis Lepetit Thomsen
Role: PRINCIPAL_INVESTIGATOR
Institute of Sports Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Physical and Occupational Therapy/Institute of Sports Medicine Copenhagen, Bispebjerg Hospital
Copenhagen NV, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-16019857
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.